INTERFERON ALFA-2B IN THE MANAGEMENT OF CHRONIC GRANULOCYTIC-LEUKEMIA

被引：6
|
作者：
BERGSAGEL, DE
机构：
来源：
CANCER TREATMENT REVIEWS | 1988年 / 15卷
关键词：
D O I：
10.1016/0305-7372(88)90069-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：15 / 20
页数：6
相关论文
共 50 条
  • [1] INTERFERON ALFA-2B IN THE TREATMENT OF CHRONIC GRANULOCYTIC-LEUKEMIA
    BERGSAGEL, DE
    HAAS, RH
    MESSNER, HA
    SEMINARS IN ONCOLOGY, 1986, 13 (03) : 29 - 34
  • [2] INTERFERON ALFA-2B IN THE TREATMENT OF CHRONIC GRANULOCYTIC-LEUKEMIA
    BERGSAGEL, DE
    HAAS, RH
    MESSNER, HA
    INVESTIGATIONAL NEW DRUGS, 1987, 5 : S9 - S17
  • [3] INTERFERON ALFA-2B IN THE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA
    NIEDERLE, N
    KLOKE, O
    OSIEKA, R
    WANDL, U
    OPALKA, B
    SCHMIDT, CG
    SEMINARS IN ONCOLOGY, 1987, 14 (02) : 29 - 35
  • [4] TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA WITH RECOMBINANT INTERFERON ALFA-2B
    NIEDERLE, N
    KLOKE, O
    MAY, D
    BECHER, R
    OSIEKA, R
    SCHMIDT, CG
    INVESTIGATIONAL NEW DRUGS, 1987, 5 : S19 - S25
  • [5] Interferon alfa-2b and cytarabine in chronic myelogenous leukemia - Reply
    Guilhot, F
    Guilhot, J
    Chastang, C
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (22): : 1634 - 1635
  • [6] RECOMBINANT INTERFERON ALFA-2B (IFN ALFA-2B) IN CHRONIC MYELOID-LEUKEMIA (CML) - INVIVO AND INVITRO RESULTS
    WANDL, UB
    NIEDERLE, N
    OPALKA, B
    KLOKE, O
    SCHMIDT, CG
    EXPERIMENTAL HEMATOLOGY, 1987, 15 (05) : 442 - 442
  • [7] Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia
    Guilhot, F
    Chastang, C
    Michallet, M
    Guerci, A
    Harousseau, JL
    Maloisel, F
    Bouabdallah, R
    Guyotat, D
    Cheron, N
    Nicolini, F
    Abgrall, JF
    Tanzer, J
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (04): : 223 - 229
  • [8] Interferon alfa-2b therapy for chronic hepatitis
    Kirchner, JT
    AMERICAN FAMILY PHYSICIAN, 1997, 55 (07) : 2434 - 2434
  • [9] CHRONIC GRANULOCYTIC-LEUKEMIA
    SPIERS, ASD
    MEDICAL CLINICS OF NORTH AMERICA, 1984, 68 (03) : 713 - 727
  • [10] Population pharmacokinetic analysis of pegylated interferon alfa-2b and interferon alfa-2b in patients with chronic hepatitis C
    Jen, JF
    Glue, P
    Ezzet, F
    Chung, C
    Gupta, SK
    Jacobs, S
    Hajian, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (06) : 407 - 421
12345